Hepatitis C virus (HCV) is an RNA virus that affects >180 million individuals worldwide with a high propensity for chronic infection. Children with HCV infection differ from adults in several ways including some modes of transmission, rates of clearance, progression of fibrosis, and the duration of potential chronic infection when acquired at birth. Since the discovery of HCV in 1989, there have been significant advances in the understanding of the virology and natural history of chronic HCV infection in children. In addition, there are now several treatment options for children with chronic hepatitis C infection and many new therapies on the horizon. As a consequence, the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition brought together experts in pediatric hepatology to review the available data in children and provide clinicians with approaches to the diagnosis, management, and prevention of HCV infection in children and adolescents. The guideline details the epidemiology and natural history of HCV infection in children, the diagnostic workup, monitoring and treatment of disease, and provides an update on future treatment options and areas of research.
2012年NASPGHAN实践指南：婴儿、儿童及青少年中HCV感染的诊断及管理
发布日期：2012-06-01
英文标题：NASPGHAN Practice Guidelines: Diagnosis and Management of Hepatitis C Infection in Infants, Children, and Adolescents
来源：J Pediatr Gastroenterol Nutr, 2012, 54(6): 838-855
阅读次数：664
Related guidelines
- 对于1945-1965年期间出生人群的慢性HCV感染检测的建议（2012年）
- APASL丙型肝炎管理指南解读
- 2012年CDC建议：出生于1945-1965年人群慢性丙型肝炎病毒感染的识别
- 积极行动，共抗丙肝
- 2012年英国基因1型慢性丙型肝炎蛋白酶抑制治疗共识指南解读
- 2012年NASPGHAN实践指南：婴儿、儿童及青少年中HCV感染的诊断及管理
- 中国丙肝医院感染防控指南（讨论稿）
- Boceprevir用于基因1型慢性HCV感染者的治疗
- 2011年美国肝病学会基因1型慢性丙型肝炎病毒感染治疗指南更新解读
- 欧洲肝病学会丙肝感染抗病毒治疗和精神健康专家共识（2012年）
- 2012年亚太肝病学会丙型肝炎病毒感染诊治共识的认识和理解
